Definition:
Studies any effect of the pharmaceutical on mammalian reproduction relevant for human risk assessment.
Assessment of nonclinical developmental and reproductive toxicity testing is required to support human clinical trials and marketing authorisation for drugs. The set of studies conducted should encompass observations through one complete life cycle (i.e., from conception in one generation through conception in the following generation) and permit detection of immediate and latent adverse effects.
More information:
Tags: